SCHEMBL14914636

SCHEMBL14914636

O=c1[nH]ncc2cccc(F)c12

nearest known ligand 0.52

Predicted protein targets (top 20)

geneUniProtsupporting neighboursconfidence
PARP1 P09874 4/20 0.52
HSD17B10 Q99714 3/20 0.52
ALDH1A1 P00352 3/20 0.52
TDP1 Q9NUW8 2/20 0.52
PRKCI P41743 1/20 0.52
PDE4B Q07343 1/20 0.52
KDM4E B2RXH2 3/20 0.45
HPGD P15428 2/20 0.45
MAPK1 P28482 1/20 0.45
TIPARP Q7Z3E1 1/20 0.40
HSP90AA1 P07900 1/20 0.39
IDO1 P14902 1/20 0.39
CDK2 P24941 1/20 0.39
NOS1 P29475 3/20 0.39
TRPA1 O75762 2/20 0.38
CA12 O43570 1/20 0.38
CA9 Q16790 1/20 0.38
TSHR P16473 2/20 0.38
DAO P14920 1/20 0.38
DDO Q99489 1/20 0.38

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL1009329 0.81 HSD17B10 (0.52) PARP1HSD17B10ALDH1A1TDP1PRKCI
SCHEMBL29280295 0.78 HSD17B10 (0.52) PARP1HSD17B10ALDH1A1TDP1PRKCI
SCHEMBL30833178 0.78 HSD17B10 (0.52) PARP1HSD17B10ALDH1A1TDP1PRKCI
SCHEMBL2478471 0.78 JAK2 (0.53) PARP1HSD17B10ALDH1A1TDP1PRKCI
SCHEMBL11412580 0.78 ALDH1A1 (0.52) PARP1HSD17B10ALDH1A1TDP1PRKCI
SCHEMBL14911424 0.78 NOS1 (0.56) PARP1HSD17B10ALDH1A1TDP1PRKCI
SCHEMBL28861461 0.75 ALDH1A1 (0.49) PARP1HSD17B10ALDH1A1TDP1PRKCI
SCHEMBL4288992 0.74 ALDH1A1 (0.67) PARP1HSD17B10ALDH1A1TDP1PRKCI
SCHEMBL25269025 0.74 HSD17B10 (0.47) PARP1HSD17B10ALDH1A1TDP1PRKCI
SCHEMBL11883656 0.74 PLK4 (0.49) PARP1HSD17B10ALDH1A1TDP1PRKCI

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 51 patents — showing the first 20. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
US-20260035354-A1 PIPERIDINEDIONE DERIVATIVES INNOCURE THERAPEUTICS, INC. (KR) 2026-02-05 US disclosed
US-12384756-B2 Piperidinedione derivatives INNOCURE THERAPEUTICS, INC. (KR) 2025-08-12 US disclosed
EP-4219478-B1 METHOD OF PREPARING AMINO PYRIMIDINE DERIVATIVES NOVARTIS AG (CH) 2025-06-11 EP disclosed
WO-2024112122-A1 DEGRADER FOR DEGRADING BRD PROTEIN AND PHARMACEUTICAL COMPOSITION CONTAINING SAME 주식회사 이노큐어테라퓨틱스 2024-05-30 WO disclosed
WO-2024112120-A1 DEGRADER INCLUDING NOVEL C-MET PROTEIN LIGAND AND PHARMACEUTICAL COMPOSITION INCLUDING SAME 주식회사 이노큐어테라퓨틱스 2024-05-30 WO disclosed
WO-2024112119-A1 DEGRADER FOR DECOMPOSING CMET PROTEIN, AND PHARMACEUTICAL COMPOSITION COMPRISING SAME 주식회사 이노큐어테라퓨틱스 2024-05-30 WO disclosed
WO-2024112119-A1 DEGRADER FOR DECOMPOSING CMET PROTEIN, AND PHARMACEUTICAL COMPOSITION COMPRISING SAME 주식회사 이노큐어테라퓨틱스 2024-05-30 WO disclosed
WO-2024112120-A1 DEGRADER INCLUDING NOVEL C-MET PROTEIN LIGAND AND PHARMACEUTICAL COMPOSITION INCLUDING SAME 주식회사 이노큐어테라퓨틱스 2024-05-30 WO disclosed
US-20230295105-A1 PIPERIDINEDIONE DERIVATIVES INNOCURE THERAPEUTICS, INC. (KR) 2023-09-21 US disclosed
US-20230295105-A1 PIPERIDINEDIONE DERIVATIVES INNOCURE THERAPEUTICS, INC. (KR) 2023-09-21 US disclosed
US-8754077-B2 8-fluorophthalazin-1(2H)-one compounds F. HOFFMANN-LA ROCHE AG (CH) 2014-06-17 US disclosed
US-20140128401-A1 8-FLUOROPHTHALAZIN-1(2H)-ONE COMPOUNDS GENENTECH, INC. (US) 2014-05-08 US disclosed
US-20140128401-A1 8-FLUOROPHTHALAZIN-1(2H)-ONE COMPOUNDS GENENTECH, INC. (US) 2014-05-08 US disclosed
US-8669251-B2 8-fluorophthalazin-1(2H)-one compounds GENENTECH, INC. (US) 2014-03-11 US disclosed
US-8669251-B2 8-fluorophthalazin-1(2H)-one compounds GENENTECH, INC. (US) 2014-03-11 US disclosed
US-8669251-B2 8-fluorophthalazin-1(2H)-one compounds GENENTECH, INC. (US) 2014-03-11 US disclosed
WO-2013067264-A1 8-FLUOROPHTHALAZIN-1 (2H) - ONE COMPOUNDS AS INHIBITORS OF BTK ACTIVITY GENENTECH, INC. (US) 2013-05-10 WO disclosed
WO-2013067264-A1 8-FLUOROPHTHALAZIN-1 (2H) - ONE COMPOUNDS AS INHIBITORS OF BTK ACTIVITY GENENTECH, INC. (US) 2013-05-10 WO disclosed
US-20130116246-A1 8-FLUOROPHTHALAZIN-1(2H)-ONE COMPOUNDS GENENTECH, INC. (US) 2013-05-09 US disclosed
US-20130116246-A1 8-FLUOROPHTHALAZIN-1(2H)-ONE COMPOUNDS GENENTECH, INC. (US) 2013-05-09 US disclosed

Patent text — is the patent's own abstract consistent with the prediction?

For each of this compound's patents that has machine-readable text (5 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.

PatentTitleText reads most aboutPredicted target · text-rank
US-20260035354-A1 PIPERIDINEDIONE DERIVATIVES CRBN, PSMC1, PSME3 PARP1 726/4885HSD17B10 3399/4885ALDH1A1 3619/4885
US-20130116246-A1 8-FLUOROPHTHALAZIN-1(2H)-ONE COMPOUNDS BTK, LCK, SYK PARP1 2276/4885HSD17B10 4160/4885ALDH1A1 4769/4885
US-20230295105-A1 PIPERIDINEDIONE DERIVATIVES CRBN, CUL1, PSMB10 PARP1 1721/4885HSD17B10 3257/4885ALDH1A1 2741/4885
US-20140128401-A1 8-FLUOROPHTHALAZIN-1(2H)-ONE COMPOUNDS BTK, LCK, SYK PARP1 1994/4885HSD17B10 4229/4885ALDH1A1 4627/4885
US-12384756-B2 Piperidinedione derivatives CRBN, CUL1, PSMB10 PARP1 1721/4885HSD17B10 3257/4885ALDH1A1 2741/4885

“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.